"The drug industry is under attack on multiple fronts, but the single biggest overhang affecting the longer-term prospects of the group is the patent 'cliff' that begins in earnest in 2011," Sanford C.
Bernstein analyst Tim Anderson said in a recent report.
tim andersonBig pharma aims to show the drugs still sellNewsvine - business Tue, 04/15/2008 - 03:03
|
